Interestingly, stromal localization and the levels of active SMAD2 (SE = 2.1) and ITGA5/ITGB1 distinguish patient-protective from patient-detrimental desmoplasia and foretell tumor recurrences. The gene discussed is ITGA5; the disease is neoplasm.